eNews
Home page > Comments


Comments

Novo Nordisk halts development of haemophilia drug

29.09.2012. | COPENHAGEN (Reuters) - Denmark's Novo Nordisk said on Friday it would discontinue development of its haemophilia drug treatment vatreptacog alfa....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: